Managing Managed Care

Our inequitable, inefficient, oftentimes uncaring health care "system," revealed. -- Jeffrey G. Kaplan, M.D., M.S.

Med. Newsletter / eBook

Be informed on reform; Newsletter + free eBook: "Mgd Care 101 in 2013" (No obligation)

Subscribe to Managing Managed Care newsletter feed

Cost is the Big Item in the Value Equation of Health Care and Here's Why

This article is posted in: 

The main tension about healthcare centers around medical need, quality, access and cost-efficiency, i.e., affordability.

To increase "value," one must raise quality, improve access and/or lower the cost of care. 

The latter, however, is an elusive goal; it is the elephant in the room. 

The unrelenting rise in medical expenditures has nearly broken the back of so many consumers, "outstripping any growth in worker's wages" and net buying power.  (See "Health Insurers Push Premiums Sharply Higher," NY Times pub. Sept. 27, 2011. http://www.nytimes.com/, esp. the graph, http://kff.org/ehbs/); It is this increasing disparity that has made the U.S. less competitive in the world market.  

Why has it been so difficult to improve the value of care?  The short answer is that the incentives are not well aligned in health care to affect quality, cost and access, simultaneously.

These factors are critically linked in both theory and in reality.  The Value Equation shows how they relate to each other and to you.

For instance, if doctors are paid fee for service, we're paying for piecework and the economic incentive in piecework is to generate pieces.  If doctors are paid prospectively (e.g., capitation or for a defined episocde of care), they may discourage services that, so to speak, they perceive comes out of their pocket.  If patients have to pay out of their pocket and they have limited cash flow, they may make compromises - delay care, get the cheaper drug or not get that drug at all.

Make patients informed consumers? It doesn't work even for doctors who are patients.  In one's hour of need, will you be sifting through comparative statistics to decide which test, doctor or emergency room to use?

Costly Care and a Dearth of Meaningful information

Even the health care manager is disadvantaged by not having good information, especially at the point of contact with the patient.  Who has access to specific outcomes data when they need it?  Even if they had it, are those data acuity-adjusted? Controlled for socio-economic differences?  Who really knows what works and what does not, which doctor or team gets the best outcomes, which insurer provides the best coverage with the least hassle?  

And, what do I mean by "disadvantaged"? Everyone is familiar with the balloon analogy--When you squeeze the healthcare balloon in one area of interest, it pops out elsewhere.

Cost-shifting and cost-sharing?  Hardly the answer here.

I'm worried.  What is the cost of care doing our fragile economy--Health care as an industry is propering and we are getting less from it. (Compare our mortality statistics to any other industrialized country.)

It's not "good news when you look into what type of health jobs propelled this strong growth. Most of it, the study authors conclude, came from an increase in administrative positions, jobs like billing specialists and office support staff. It’s quite likely that more people with health insurance mean more resources necessary to bill insurance companies and administer the business of health care.

An increase in those kind of jobs is great for employment. But it’s not so great for health care costs. It’s part of the reason that American doctors have administrative costs four times higher than their Canadian counterparts. It likely contributes to growing health care costs that have eaten up nearly a decade worth of increased earnings. And it’s why, at the same time that health care jobs increase, we also have graphs like this:

Ref. Sarah Kliff, writing at Ezra Klein’s blog

SPENDING MORE ON HEALTHCARE IN THE U.S. GETTING LESS

It's old news, importantly repackaged by the Commonwealth Fund —We spend more on health care than 12 comparable, industrialized countries but, we seem to get less for it, i.e., our per capita cost is $8 grand compared with, for example, "Norway and Switzerland, spending a little more than $5 grand.  Our charges are rediculous and the variation in sharges unexplainable and, comparent with elsewhere, intolerably high.  We, however, provide less doctor consultations; we have less hospital beds, shorter hospital stays, variable quality and our results, are not outstanding, if better at all.  OTOH, we pay dearly for medication and medical services, and our love affair with expensive technology—'Forget about it'—it has no bounds. The prevalence of obesity in our country is ponderous, while our population is clearly more sedentary.

D. A. Squires. "The U.S. Health System in Perspective: A Comparison of Twelve Industrialized Nations," The Commonwealth Fund, July 2011.

R. Zimlich. "U.S. Outspends Other Industrialized Nations on Healthcare With Mixed Results." Medical Economics  May 23, 2012


I asked a colleague on a mutual advocacy group, HARP.org to please elaborate on the fact that our pricing is out of wack and unsupportable and then there's the technological Imperative.  And, our outcomes are no better, sometimes worse than othe countires with more affordable health care....,

Lou....
The marketplace is where these obscene price disparities will be brought to light. Do you get optimal care? Is it cost-effective? Does it benefit?

The ACA has provisions for pay for performance, but little in the way of performance measurement and certainly nothing in terms of feedback in real time (I.e., at the point of contact with the patient in ALL settings.  

I am always "HARPing" (with reference to a Board I am on, www.HARP.org) on 'measurement and management,' incentive realignment and giving a hand up to primary care.  Is it happening somewhere; maybe I missed something?  Without these management techniques and the way we pay docs and systems of care, reform's merely a shell game !


OTOH, there's hope:

See: "Study: Pateint-Centered Medical Home quality, costs linked." Modern Medicine June 26, 2012 where care was evaluated in six subscales:

  1. access/communication,

  2. care management,

  3. external coordination,

  4. patient tracking,

  5. test/referral tracking, and

  6. quality improvement.

Quoting the venerable Dr. Arnold S. Relman of the New England Journal of Medicine fame, "This problem [the lack of 'practical suggestions'] is a direct result of "the inappropriate organization and perverse economic incentives of a health care Top Ten delivery system that motivates physicians and medical institutions to maximize their income rather than focus on optimal patient care.”


The Top 10 Challenges to Managing Cost, Quality and Access for The Sake of Affordability and Benefit:

  1. Value: to enhance it, practitioners must be aligned to minimize Cost while maximizing Quality and Access
  2. Pay for what works well. Money's the main stimulus: management suffers from always having inadequate provider incentives
  3. Information technology (IT) It has limitations—live with it! And, don't expect it will save money; in fact it may do the opposite.   Regardless, understand the difference between data and information because information may improve the cost and quality of care, applied well, but data that's not imnformation -- all you may see from data is its use in upcoding and as justification for charges.*
  4. Measure and manage; this is the essence of managing care and improving care management; it requires that data be translated into information (If there's no EHR data, use claims data).  Use it to build—
  5. Episodes of carea fundamental of health care statistical analysis; it is a grouper technique that shows all care over time, regardless of setting and it is case-mix or acuity-adjusted
  6. Outcomesthe key parameter of what we want to reward; clinical results, strangely, are neither tracked nor optimized in most health care practices
  7. Case or disease management
  8. Guidelines/pathways—medical and surgical
  9. Lack of patient loyalty or engagement—Not knowing who's in your panel or health plan, patient attribution is one of the main stumbling blocks of today's version of managed care--Accountable Care Organizstions and Medical Homes. Other obstacles are  job-lock, denying coverage for 'pre-existing conditions,' waiting periods, barriers to access such as heavy co-pays and deductibles, employer-based insurance in general and state border restrictions--what nonsense)
  10. Defensive medicine is a distraction and it is insidiously costly, despite claims to the contrary

* See "In 2nd Look, Few Savings from Digital Health Records," by Reed Ableson and Julie Oreswell, NY Times, Jan. 10 2013; it speaks to a RAND Corporation study, the "2005 Report"  that grossly overstated expected savings.

The above "Ten challenges"all speak to the critical management issue of incentive alignment.  To elaborate....The commonality of various payment methods such as pay-for-performance (P4P), capitation, bundled payments, withholds/risk pools, and shared savings is that there's to be some degree of financial accountability for medical expenditures.

"To be successful under budget-based payment models, physician practices must be able to accurately predict the future utilization of services by their patient populations and how much it will cost their practices to deliver medical services. Then the key is managing patient care in a way that sticks to the budget."

"Some mix FFS payments with an opportunity to earn additional money if quality and cost metrics are met (shared savings and pay-for-performance [PFP]), others offer only set flat rates for either a package of services (bundled payments), pay a fee each month on a per-member basis (capitation), or set aside some portion of contractual payments, which are paid only if providers meet pre-established goals (withholds and risk pools)."

Lisa Zamosky. "Fractured Income; Emerging reimbursement models pose new risks." Medical Economics. Jun 10, 2012 [Last accessed 12/24/2012]

Comments

Sara Jackson in "Report: Pricing, technology to blame for high U.S. healthcare costs" in FierceHealthIT (May 3, 2012) points to charges and the cost of new, not necessarily cost-effective technology as the main drivers of health care cost inflation, not utilization.

"The U.S. uses far more MRIs, CT scans, PET scans and mammograms.
What's more, those tests are far more expensive in the U.S. than in other countries. For example, an MRI costs about $1,080 in the U.S., versus $299 in France and $599 in Germany.....[However, the] U.S. has the lowest physician visit rates (3.9 per capita), among the shortest hospital lengths of stay, and some of the lowest hospital discharge rates (per thousand) of any of the countries studied in the report...."The higher prices we pay for healthcare and perhaps our greater use of expensive technology are the more likely explanations for high health spending in the U.S."
To learn more:
- read the Commonwealth Fund report (.pdf)

Harvey Frey, MD, PhD, JD writing on HARP.org
http://lists.harp.org/listinfo/dialog

As with everything else in American politics, it is "off the table" to do anything about the profits of the wealthy, and every financial problem needs to be taken out of the hides of the poor.

That is why instead of asking why, for example, MRIs are so expensive, we demand that fewer of them be used for patients who need them.

To ask why they're so expensive, we'd have to address the profiteering of equipment manufacturers and middlemen, and the pricing policies of hospitals and radiologists, who attempt to amortize equipment costs over an irrationally short period of time. And that's a NoNo, because those people are wealthy and have political clout.

Why don't we have "Medicare For All"? Because the first priority is not to improve health care, but to preserve the profits of health insurance companies.

Why is bargaining over drug prices banned in Medicare part D? Because we must preserve the profits of Big Pharma, while pretending to care about patients getting needed drugs. And putting in a 'doughnut hole', to be sure that desideratum is satisfied.

And, though the main guilt lies with venal legislatures, courts, and billionaires, there's plenty of guilt at the doorstep of the U.S. Population - the 99%.

Yes, the Nine Nutcases have given the billionaires carte blanche to spend as much money as they want to buy elections.

But - all they can buy is Advertising! It is the nincompoop 99% who allow themselves to be influenced by the ads bought by the 1%, and who consistently vote against their own interests and the common good.

Harvey

Cutler and Ly compare the U.S. and Canada in terms of spending difference in health care saying it is more than price, visit, pharmaceutical or hospital day differences.  The differences are not even attributable to the disparity in doctor or health care professionals' earning.  Obviously Canada has a single payer system and the U.S., a mixture of public and private "insurance."  [Drum roll, please] the "largest quantitative difference in healthcare spending betweenness the United States and Canada is administrative costs." [p.5] and we are "spending more to get less." [p.23, "The Paper (Work) of Medicine"]



Caveat: In health care reform, there will be disgruntlement.  For instance, the authors add, for the record that "The theory of social insurance justifies imposing at least some hassles to screen out less-valuable from more-valuable care." ["Targeting Transfers"]


Cutler and Ly recommend economic research to the end of creating more value in health care where the main foci are: 



  1. Administrative simplification.

  2. Information technology that will show when care is "appropriate, where it falls short, and what each patient has already received."

  3. Payment reform, "essential to encourage providers to carefully consider which care is of high and low value and to provide incentives for better chronic care manageemnt." 

  4. "Finally, value-based cost-sharing is important to provice people with incentives to use valuable care and discourage less-valuable care." [Conclusion, "The Paper (Work) of Medicine"; p.22].


Cutler DM, Ly DP.“The (Paper) Work of Medicine: Understanding International Medical Costs.” Journal of Economic Perspectives. Spring 2011;25(2):3–25


Nichols AL, Zeckhauser RJ. “Targeting Transfers through Restrictions on Recipients.” American Economic Review.” 72(2): 372-77.

Pages

Add new comment